PCCs are shown to produce excess chemokines that are heavily involved in the activation of Cancer-associated fibroblasts, including CXCL1, -5, and -8 binding to fibroblasts’ CXCR2 receptors, leading to increased fibroblast activation and reprogramming (23). The gene discussed is CXCL1; the disease is cancer.